ENCELLIN
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
ENCELLIN
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.encellin.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Organization Schema Google Apps For Business GoDaddy DNS Typekit Squarespace
Similar Organizations
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Inito
Inito is the world’s first comprehensive at-home diagnostics device & App.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
Current Advisors List
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Seed Round - Encellin
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Encellin
SV Latam Capital
SV Latam Capital investment in Seed Round - Encellin
Khosla Ventures
Khosla Ventures investment in Seed Round - Encellin
Formic Ventures
Formic Ventures investment in Seed Round - Encellin
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Encellin
Khosla Ventures
Khosla Ventures investment in Seed Round - Encellin
Y Combinator
Y Combinator investment in Seed Round - Encellin
MedTech Innovator
MedTech Innovator investment in Grant - Encellin
Official Site Inspections
http://www.encellin.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Encellin"
About Us — Encellin
Encellin was founded based on the technology developed in the lab of Dr. Tejal Desai at the University of California in San Francisco. Encellin is a team of dedicated experts focused on the investigation and advancement of next …See details»
Encellin - Crunchbase Company Profile & Funding
Encellin may be growing as it has recently closed a significant financing round, securing $9.9 million to support the development of its implantable drug delivery pouch. This funding indicates investor confidence and provides the financial …See details»
Encellin, Inc. Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Encellin, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Encellin Company Profile 2024: Valuation, Funding
Encellin General Information Description. Operator of a biotechnology company intended to develop a novel thin-film cell encapsulation device for cell-based therapeutics. The company's device uses thin-film cell delivery technology that …See details»
Encellin Company Profile - Office Locations, Competitors ... - Craft
Encellin has 5 employees at their 1 location and $5.9 m in total funding,. See insights on Encellin including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Encellin | Company | RadialReport
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. …See details»
Encellin - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Encellin . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. Encellin has 5 current employee profiles, …See details»
Encellin - LinkedIn
Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our …See details»
Encellin - Updates, News, Events, Signals & Triggers - Crunchbase
Encellin may be growing as it has recently closed a significant financing round, securing $9.9 million to support the development of its implantable drug delivery pouch. This funding …See details»
Encellin - UCSF Rosenman Institute
Sep 11, 2022 Encellin is developing a novel thin-film cell encapsulation device for cell-based therapeutics.See details»
Encellin - VentureRadar
Encellin is a biotechnology company that specializes in the development of a cell encapsulation platform. The company's initial focus is on Type 1 Diabetes (T1D). Their innovative …See details»
Encellin Closes $9.9M Financing Led by Khosla Ventures to …
Dec 13, 2023 Encellin’s cell encapsulation platform is approved for clinical trials in Type 1 Diabetes, a condition impacting 1.6 million people in the US and a gateway opportunity to …See details»
Encellin - Golden
Encellin is developing diabetes therapeutics using insulin responsive cells. Encellin aims to safely replace missing, damaged, or diseased cells in the body with next generation cell transplants. …See details»
Encellin - Funding, Financials, Valuation & Investors - Crunchbase
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much funding …See details»
Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures …
Aug 5, 2021 Encellin is developing regenerative materials using cell transplant therapy. The company has developed cell transplant therapy for treating missing, damaged, or diseased …See details»
Encellin Raises $5.9M in Seed Financing - FinSMEs
Aug 9, 2021 Encellin, a San Francisco, CA-based personalized regenerative medicine biotech company developing novel cell-based approaches to deliver sustained therapies with a single …See details»
Technology — Encellin
Encellin’s initial pipeline focuses on endocrine disorders with clear mechanism of action. The proprietary Encellin platform utilizes well known biocompatible materials fabricated into nano …See details»
How a startup with a pouch of cells looks to change diabetes
Aug 5, 2021 The money will help Encellin move its plans forward, though Nyitray won't give a timeline for when Encellin hopes to start clinical trials in humans. But the pouch technology …See details»
Blog 2 — Encellin
Encellin today announced the closing of a $5.9M Seed financing round, co-led by Khosla Ventures and SV Latam Capital, with participation from Sandhill Angels and Y Combinator. …See details»